Heart Clinical Trials

1,521 recruitingLast updated: June 18, 2026

There are 1,521 actively recruiting heart clinical trials across 94 countries. Studies span Not Applicable, Phase 2, Phase 4, Phase 3, Phase 1, Early Phase 1. Top locations include New York, New York, United States, Boston, Massachusetts, United States, Dallas, Texas, United States. Updated daily from ClinicalTrials.gov.


Heart Trials at a Glance

1,521 actively recruiting trials for heart are listed on ClinicalTrialsFinder across 6 cities in 94 countries. The largest study group is Not Applicable with 615 trials, with the heaviest enrollment activity in New York, Boston, and Dallas. Lead sponsors running heart studies include Mayo Clinic, Yale University, and Assistance Publique - Hôpitaux de Paris.

Treatments under study

About Heart Clinical Trials

Looking for clinical trials for Heart? There are currently 2 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Heart trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Heart clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 1,521 trials

Recruiting
Not Applicable

Management of Patients With Heart Failure at Home After Hospital Discharge

Heart Failure
University Hospital, Akershus450 enrolled11 locationsNCT06576752
Recruiting
Not Applicable

Mobile-Based Telemedicine and Health-Related Quality of Life Among Patients With Chronic Heart Failure (MOBILE-HF)

Health-related Quality of LifeChronic Heart Failure
Select College72 enrolled1 locationNCT07650474
Recruiting
Not Applicable

Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold (RMS) System in Subjects With Coronary Artery Lesions

Arterial Occlusive DiseasesPainCardiovascular Diseases+12 more
Teleflex1,859 enrolled1 locationNCT07258290
Recruiting

Deep Learning Detection of Pulmonary Hypertension and Low Ejection Fraction Via Digital Stethoscope and 3-Lead ECG

Heart Failure With Reduced Ejection FractionHypertension, Pulmonary
Eko Devices, Inc.3,850 enrolled4 locationsNCT07087613
Recruiting

Palliative Care for People With HF

Congestive Heart FailureCongestive Heart Failure(CHF)Congestive Heart Failure Chronic
Indiana University20 enrolled1 locationNCT07356843
Recruiting

Effect of Dapagliflozin on Right Ventricular-Pulmonary Artery Coupling After Off-Pump Coronary Atery Bypass Grafting

Heart FailureCoronary Arterial Disease
Pyatigorsk City Clinical Hospital Number 172 enrolled1 locationNCT07601867
Recruiting

Dietary Tracking in Heart Failure

Heart FailureNYHA Class III Heart FailureNYHA Class II Heart Failure
The Cleveland Clinic60 enrolled1 locationNCT07649148
Recruiting

Ultrathin Strut Sirolimus-eluting Stent With Bioabsorbable Polymer in Patients Receiving Chronic Oral Anticoagulation

Coronary Artery DiseaseIschemic Heart Disease
Fundación EPIC500 enrolled12 locationsNCT06863155
Recruiting
Not Applicable

Efficacy of Transcutaneous Auricular Vagus Nerve Stimulation on Alleviating Major Depressive Disorder in Patients With Acute Coronary Syndrome After Percutaneous Coronary Intervention:A Prospective, Double-Blind,Randomized Controlled Study

Depressive DisorderPercutaneous Coronary Intervention (PCI)Acute Coronary Syndrome (ACS)+5 more
Jing Han120 enrolled1 locationNCT07454070
Recruiting

Personalized Environment and Genes Study

AsthmaDiabetesHeart Disease
National Institute of Environmental Health Sciences (NIEHS)25,000 enrolled2 locationsNCT00341237
Recruiting
Phase 3

A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure

Heart Failure
Boehringer Ingelheim6,000 enrolled652 locationsNCT06424288
Recruiting
Not Applicable

Effectiveness of Video Monitoring and Care Transition for Heart Failure Patients (EVIT-HF): Randomized Clinical Trial

Heart Failure With Reduced Ejection Fraction (HFrEF)
Federal University of Uberlandia140 enrolled1 locationNCT06731166
Recruiting
Phase 3

A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction

Left Ventricular Systolic DysfunctionHeart Failure (Pediatric)
Bayer111 enrolled133 locationsNCT07188805
Recruiting

Wearable Technology in Heart Failure Patients

Heart Failure
The Cleveland Clinic500 enrolled1 locationNCT07650669
Recruiting

A Study to Learn More About the Safety of the Drug Vericiguat in Japanese People With Chronic Heart Failure Who Will be Receiving Vericiguat Under Real-world Conditions

Chronic Heart Failure
Bayer1,400 enrolled1 locationNCT05666518
Recruiting
Not Applicable

RCT of Implantable Defibrillators in Patients With Non Ischemic Cardiomyopathy, Scar and Severe Systolic Heart Failure

Heart Failure
University Hospital Southampton NHS Foundation Trust2,504 enrolled47 locationsNCT05568069
Recruiting

An Observational Study to Learn More About the Use of Vericiguat in Korean People With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF) in Real-world Setting

Chronic Heart Failure With Reduced Ejection Fraction
Bayer1,350 enrolled1 locationNCT06148935
Recruiting

The Mycophenolate Pregnancy Registry

Heart Transplantation, Kidney Transplantation, Liver Transplantation, Autoimmune Diseases
Genentech, Inc.500 enrolled1 locationNCT01733082
Recruiting

MULTIVALVE : A Prospective Multicentre Study of Multiple and Mixed Valvular Heart Disease

Valvular Heart Disease
French Cardiology Society1,000 enrolled2 locationsNCT07176507
Recruiting
Not Applicable

Quantifying New Heart Muscle Cells

Heart FailureTetralogy of Fallot With Pulmonary Stenosis
Weill Medical College of Cornell University30 enrolled4 locationsNCT06587165